Mobile

Study to evaluate the safety and pharmacokinetics of ciprofloxacin following inhalation of ciprofloxacin dry powder for inhalation administered to pediatric patients with cystic fibrosis aged 12-17 ye...

Update Il y a 5 ans
Reference: EUCTR2007-002912-24

Study to evaluate the safety and pharmacokinetics of ciprofloxacin following inhalation of ciprofloxacin dry powder for inhalation administered to pediatric patients with cystic fibrosis aged 12-17 years

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Primary objective of the study is to investigate the safety and tolerability of inhaled ciprofloxacin given as single inhalation dose to pediatric CF patients.

Inclusion criteria

  • long term treatment of chronic lung infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis

Links